PD-L1 expression is upregulated on tumour cells or tumour microenvironments such as tumour-infiltrating lymphocyte, and decreases T cell activity by binding to PD-1 on tumour antigen-specific T cell (5, 7, 8). This evidence concerns the gene PDCD1 and neoplasm.